Journal
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
Volume 12, Issue 3, Pages 294-302Publisher
TERMEDIA PUBLISHING HOUSE LTD
DOI: 10.5114/jcb.2020.96874
Keywords
nasopharyngeal carcinoma; interstitial brachytherapy boost; image-guided brachytherapy
Funding
- Japan Agency for Medical Research and Development (AMED) [19ck0106305h0003]
- National Cancer Center Research and Development Fund [26-A-18, 26-A-28]
- Project of Social Development Division in Department of Science and Technology of Jilin Province [20190303151SF]
Ask authors/readers for more resources
Nasopharyngeal cancer generally responds well to concurrent chemoradiotherapy (CCRT). However, there is a small group of patients who respond poorly to CCRT, and experience local residual tumor or local relapse. Although several attempts have been performed to such a group of patients including re-irradiation with external beam radiation therapy (EBRT) or salvage surgery, clinical results remain unsatisfactory. Intracavitary brachytherapy (ICBT) boost after CCRT with EBRT has been explored, however, its efficacy is limited to those with superficial residual tumors. For those residual tumors thickness with more than 5 mm, interstitial brachytherapy (ISBT) boost would be an appropriate modality of choice. Here, we describe technical aspects of the high-dose-rate interstitial brachytherapy (HDR-ISBT) boost for nasopharyngeal cancer (NPC) patients who responded poorly to the CCRT with EBRT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available